257 related articles for article (PubMed ID: 32375860)
1. Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT.
Sanz J; Galimard JE; Labopin M; Afanasyev B; Angelucci E; Ciceri F; Blaise D; Cornelissen JJ; Meijer E; Diez-Martin JL; Koc Y; Rovira M; Castagna L; Savani B; Ruggeri A; Nagler A; Mohty M;
J Hematol Oncol; 2020 May; 13(1):46. PubMed ID: 32375860
[TBL] [Abstract][Full Text] [Related]
2. Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT.
Sanz J; Galimard JE; Labopin M; Afanasyev B; Sergeevich MI; Angelucci E; Kröger N; Koc Y; Ciceri F; Diez-Martin JL; Arat M; Sica S; Rovira M; Aljurf M; Tischer J; Savani B; Ruggeri A; Nagler A; Mohty M
J Hematol Oncol; 2021 May; 14(1):84. PubMed ID: 34049582
[TBL] [Abstract][Full Text] [Related]
3. Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors.
Brissot E; Labopin M; Moiseev I; Cornelissen JJ; Meijer E; Van Gorkom G; Rovira M; Ciceri F; Griskevicius L; Blaise D; Forcade E; Mistrik M; Mielke S; Bulabois CE; Niittyvuopio R; Deconinck E; Ruggeri A; Sanz J; Spyridonidis A; Savani B; Giebel S; Nagler A; Mohty M
J Hematol Oncol; 2020 Jul; 13(1):87. PubMed ID: 32620146
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus Reactivations in Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Matched and Haploidentical Donors with Post-Transplantation Cyclophosphamide.
Chorão P; Henriques M; Villalba M; Montoro J; Balaguer-Roselló A; González EM; Gómez MD; Gómez I; Solves P; Santiago M; Asensi P; Lamas B; Bataller A; Granados P; Eiris J; Martínez D; Louro A; Rebollar P; Perla A; Salavert M; de la Rubia J; Sanz MÁ; Sanz J
Transplant Cell Ther; 2024 May; 30(5):538.e1-538.e10. PubMed ID: 38331195
[TBL] [Abstract][Full Text] [Related]
5. HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus HLA-Matched Unrelated Donor Transplantation for Myelodysplastic Syndrome.
Nakaya Y; Koh H; Konuma T; Shimomura Y; Ishiyama K; Itonaga H; Hino M; Doki N; Nishida T; Ohigashi H; Matsuoka KI; Kanda Y; Maruyama Y; Sawa M; Eto T; Hiramoto N; Fukuda T; Atsuta Y; Nakamae H
Transplant Cell Ther; 2024 Mar; 30(3):316.e1-316.e12. PubMed ID: 38108263
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Maffini E; Labopin M; Kröger N; Finke J; Stelljes M; Schroeder T; Einsele H; Tischer J; Bornhäuser M; Bethge W; Brecht A; Rösler W; Dreger P; Schäfer-Eckart K; Passweg J; Blau IW; Nagler A; Ciceri F; Mohty M
Bone Marrow Transplant; 2024 Mar; ():. PubMed ID: 38555412
[TBL] [Abstract][Full Text] [Related]
7. Post-transplant сyclophosphamide after matched donor hematopoietic stem cell transplantation in children with acute leukemia.
Borovkova AS; Paina OV; Semenova EV; Bykova TA; Osipova AA; Slesarchuk OA; Kozhokar PV; Tsvetkova LA; Rakhmanova ZZ; Kozlov AV; Chukhlovin AB; Kazantsev IV; Estrina MA; Goloshchapov OV; Bondarenko SN; Moiseev IS; Kulagin AD; Zubarovskaya LS
Clin Transplant; 2024 Jan; 38(1):e15181. PubMed ID: 37922213
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma.
Nakaya Y; Nakamae H; Nishikubo M; Kondo E; Fukuda T; Hiramoto N; Mori Y; Nagafuji K; Eto T; Onishi Y; Uchida N; Ishikawa J; Matsuoka KI; Yui S; Takase K; Kawakita T; Kanda J; Ichinohe T; Atsuta Y; Kako S
Bone Marrow Transplant; 2024 May; 59(5):630-636. PubMed ID: 38355911
[TBL] [Abstract][Full Text] [Related]
9. Haploidentical stem cell donor choice for patients with acute myeloid leukemia: a study from the ALWP of the EBMT.
Sanz J; Labopin M; Blaise D; Raiola AM; Busca A; Vydra J; Tischer J; Chevallier P; Bramanti S; Fanin R; Socié G; Forcade E; Kröger N; Koc Y; Itäla-Remes M; Zecca M; Nagler A; Brissot E; Spyridonidis A; Bazarbachi A; Giebel S; Piemontese S; Mohty M; Ciceri F
Blood Adv; 2024 May; 8(10):2332-2341. PubMed ID: 38429091
[TBL] [Abstract][Full Text] [Related]
10. ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
Penack O; Abouqateb M; Peczynski C; Boreland W; Kröger N; Stelljes M; Gedde-Dahl T; Blau IW; Schroeder T; Salmenniemi U; Kulagin A; Peffault de Latour R; Mielke S; Zeiser R; Moiseev I; Schoemans H; Koenecke C; Peric Z
Leukemia; 2024 May; 38(5):1156-1163. PubMed ID: 38538862
[TBL] [Abstract][Full Text] [Related]
11. Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes Demonstrates Long Term Survival, Results from Australia and New Zealand Transplant and Cellular Therapies.
Abadir E; Othman J; Kwan J; Gottlieb DJ; Kennedy GA; Bajel A; Doocey R; Perera T; Watson AM; Bardy PG; Greenwood M; Curtis DJ; Tran S; Moore J; Hamad N
Transplant Cell Ther; 2024 Mar; 30(3):334.e1-334.e7. PubMed ID: 38029962
[TBL] [Abstract][Full Text] [Related]
12. Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia.
Nagler A; Kanate AS; Labopin M; Ciceri F; Angelucci E; Koc Y; Gülbas Z; Arcese W; Tischer J; Pioltelli P; Ozdogu H; Afanasyev B; Wu D; Arat M; Peric Z; Giebel S; Savani B; Mohty M
Haematologica; 2021 Jun; 106(6):1591-1598. PubMed ID: 32354866
[TBL] [Abstract][Full Text] [Related]
13. Incidence and Impact of Fungal Infections in Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis and Haploidentical Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis.
Papanicolaou GA; Chen M; He N; Martens MJ; Kim S; Batista MV; Bhatt NS; Hematti P; Hill JA; Liu H; Nathan S; Seftel MD; Sharma A; Waller EK; Wingard JR; Young JH; Dandoy CE; Perales MA; Chemaly RF; Riches M; Ustun C
Transplant Cell Ther; 2024 Jan; 30(1):114.e1-114.e16. PubMed ID: 37775070
[TBL] [Abstract][Full Text] [Related]
14. Posttransplant cyclophosphamide versus anti-thymocyte globulin versus combination for graft-versus-host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party.
Bazarbachi AH; Labopin M; Raiola AM; Blaise D; Arcese W; Santarone S; Koc Y; Bramanti S; Kulagin A; Kwon M; Sica S; Sanz J; Brissot E; Nagler A; Ciceri F; Mohty M
Cancer; 2024 May; ():. PubMed ID: 38758817
[TBL] [Abstract][Full Text] [Related]
15. Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
Brissot E; Labopin M; Stelljes M; Ehninger G; Schwerdtfeger R; Finke J; Kolb HJ; Ganser A; Schäfer-Eckart K; Zander AR; Bunjes D; Mielke S; Bethge WA; Milpied N; Kalhs P; Blau IW; Kröger N; Vitek A; Gramatzki M; Holler E; Schmid C; Esteve J; Mohty M; Nagler A
J Hematol Oncol; 2017 Jun; 10(1):130. PubMed ID: 28646908
[TBL] [Abstract][Full Text] [Related]
16. Posttransplant cyclophosphamide beyond haploidentical transplantation.
Arcuri LJ; Ribeiro AAF; Hamerschlak N; Kerbauy MN
Ann Hematol; 2024 May; 103(5):1483-1491. PubMed ID: 37261557
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in haploidentical transplantation with post-transplant cyclophosphamide for acute myeloid leukemia.
Shibata S; Arai Y; Kondo T; Mizuno S; Yamasaki S; Akasaka T; Doki N; Ota S; Maruyama Y; Matsuoka KI; Nagafuji K; Eto T; Tanaka T; Ohigashi H; Nakamae H; Onizuka M; Fukuda T; Atsuta Y; Yanada M
Cytotherapy; 2024 Jun; 26(6):592-598. PubMed ID: 38466265
[TBL] [Abstract][Full Text] [Related]
18. Haploidentical and matched unrelated donor allogeneic hematopoietic stem cell transplantation offer similar survival outcomes for acute leukemia.
Wang YC; Lai CL; Chen TC; Gau JP; Teng CJ
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2060. PubMed ID: 38600053
[TBL] [Abstract][Full Text] [Related]
19. Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT.
Montoro J; Eikema DJ; Tuffnell J; Potter V; Kałwak K; Halkes CJJ; Kulagin A; Collin M; Wynn RF; Robinson S; Nicholson E; Sengeloev H; Halahleh K; Skorobogatova E; Sanz J; Passweg JR; Mielke S; Ryhänen SJ; Carpenter B; Gedde-Dahl T; Tholouli E; Fanin R; Lewalle P; Kulasekararaj AG; Risitano AM; Peffault de Latour R
Blood; 2024 Apr; ():. PubMed ID: 38643511
[TBL] [Abstract][Full Text] [Related]
20. Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation.
Fuji S; Sugita J; Najima Y; Konishi T; Tanaka T; Ohigashi H; Eto T; Nagafuji K; Hiramoto N; Matsuoka KI; Maruyama Y; Ota S; Ishikawa J; Kawakita T; Akasaka T; Kamimura T; Hino M; Fukuda T; Atsuta Y; Yakushijin K
Br J Haematol; 2024 Mar; 204(3):959-966. PubMed ID: 38037468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
